Xeris Biopharma Holdings, Inc.XERSNASDAQ
Loading
Total Costs & Expenses Over TimeExpanding
Percentile Rank100
3Y CAGR+11.6%
5Y CAGR+20.8%
Year-over-Year Change
Total of all costs and expenses
3Y CAGR
+11.6%/yr
vs +32.8%/yr prior
5Y CAGR
+20.8%/yr
Recent deceleration
Acceleration
-21.2pp
Decelerating
Percentile
P100
Near historical high
vs 5Y Ago
2.6x
Strong expansion
Streak
5 yr
Consecutive growthExpanding
| Period | Value | YoY Change |
|---|---|---|
| TTM | $266.95M | +12.8% |
| 2024 | $236.72M | +13.8% |
| 2023 | $207.92M | +8.2% |
| 2022 | $192.19M | +16.7% |
| 2021 | $164.75M | +58.4% |
| 2020 | $103.98M | -16.9% |
| 2019 | $125.10M | +102.4% |
| 2018 | $61.81M | +119.3% |
| 2017 | $28.18M | +97.0% |
| 2016 | $14.31M | - |